U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 18
LIST OF TABLES
• TABLE 26
CANCER INCIDENCE RATE IN THE U.S., BY REGION (PER 100,000 INDIVIDUALS), 2008–2012.....................66
• TABLE 27
U.S. IVD MARKET SIZE, FOR ONCOLOGY/CANCER BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................66
• TABLE 28
U.S. IVD MARKET SIZE, FOR CARDIOVASCULAR DISORDERS BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................68
• TABLE 29
OBESITY INCIDENCE RATE IN THE U.S., BY REGION (PER 100,000 INDIVIDUALS), 2008–2012.....................69
• TABLE 30
U.S. IVD MARKET SIZE, FOR ENDOCRINE DISORDERS BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................69
• TABLE 31
ARTHRITIS INCIDENCE IN THE U.S., BY REGION, 2011 & 2013.......................................................................70
• TABLE 32
U.S. IVD MARKET SIZE, FOR AUTOIMMUNE DISEASES BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................70
• TABLE 33
U.S. IVD MARKET SIZE, FOR BONE & MINERAL-RELATED DISEASES BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................71
• TABLE 34
ASTHMA PREVALENCE IN THE U.S., BY AGE, 2007-2011................................................................................72
• TABLE 35
U.S. IVD MARKET SIZE, FOR PULMONARY DISEASES BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................72
• TABLE 36
U.S. IVD MARKET SIZE, FOR OTHER APPLICATIONS BY END USER,
2013–2020 (USD MILLION)...............................................................................................................................73
• TABLE 37
U.S.: IVD MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)..............................................................75
• TABLE 38
U.S.: IVD MARKET SIZE FOR HOSPITAL LABORATORIES, BY REGION,
2013–2020 (USD MILLION)...............................................................................................................................76
• TABLE 39
U.S.: IVD MARKET SIZE FOR HOSPITAL LABORATORIES, BY APPLICATION,
2013–2020 (USD MILLION)...............................................................................................................................77
• TABLE 40
U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY REGION,
2013–2020 (USD MILLION)...............................................................................................................................78
• TABLE 41
U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY APPLICATION,
2013–2020 (USD MILLION)...............................................................................................................................79
• TABLE 42
U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY LABORATORY SIZE,
2013–2020 (USD MILLION)...............................................................................................................................79
• TABLE 43
U.S.: IVD MARKET SIZE FOR OTHER END USER, BY REGION,
2013–2020 (USD MILLION)...............................................................................................................................81
• TABLE 44
U.S.: IVD MARKET SIZE FOR OTHER END USERS, BY APPLICATION,
2013–2020 (USD MILLION)...............................................................................................................................82
• TABLE 45
GROWTH STRATEGY MATRIX, 2012–2015........................................................................................................84
[email protected]
www.marketsandmarkets.com
18